Chest:过敏性肺炎的影像学表型与不同生存时间和肺功能轨迹相关

2018-09-22 xing.T MedSci原创

由此可见,该研究在HP患者中鉴定出三种预后不同的影像学表型。强调了在非蜂窝纤维化患者中进行特定诊断(例如HP与IPF)的重要性。当存在放射性蜂窝结构时,鉴于预后均一,针对确定诊断的有创检查可能价值有限。

过敏性肺炎(HP)是一种间质性肺病,一般而言比特发性肺纤维化(IPF)预后更好。近日,呼吸领域权威杂志chest上发表了一篇研究文章,研究人员通过影像学表型比较了HP和IPF患者的生存时间和肺功能轨迹。

经手术/经支气管肺活检、支气管肺泡灌洗和提示HP诊断的接触史则诊断为HP患者(n=117)。IPF患者(n=161)经临床和组织病理学诊断。所有参与者均具有基线高分辨率CT(HRCT)和%预测的用力肺活量(FVC%)的数据。三位胸部放射科医师记录了放射学特征。生存时间从HRCT检查到死亡或肺移植的时间。Cox比例风险模型用于识别与生存时间相关的变量。线性混合模型比较了HRCT检查后FVC%的轨迹。

通过临床诊断和三种相互排斥的放射学表型对受试者进行分组:蜂窝存在、存在非蜂窝纤维化(牵拉性支气管扩张和网状)、非纤维化。非纤维化HP患者的无事件中位生存期最长(>14.73年)并且具有改善的FVC%(1.92%; 95%CI为0.49-3.35; p=0.009)。非蜂窝纤维化的HP患者比IPF患者具有更长的存活期(>7.95 vs. 5.20年),并且两组都经历了FVC%的显著下降。蜂窝组织的HP和IPF受试者存活期较低(分别为2.76和2.81年),FVC%显著下降。

由此可见,该研究在HP患者中鉴定出三种预后不同的影像学表型。强调了在非蜂窝纤维化患者中进行特定诊断(例如HP与IPF)的重要性。当存在放射性蜂窝结构时,鉴于预后均一,针对确定诊断的有创检查可能价值有限。

原始出处:

Margaret L. Salisbury,et al. Hypersensitivity Pneumonitis: Radiologic Phenotypes are Associated with Distinct Survival Time and Pulmonary Function Trajectory.chest.2018. https://doi.org/10.1016/j.chest.2018.08.1076

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1808550, encodeId=aabd18085507d, content=<a href='/topic/show?id=02918204162' target=_blank style='color:#2F92EE;'>#肺功能轨迹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82041, encryptionId=02918204162, topicName=肺功能轨迹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a44345, createdName=yulin2006, createdTime=Sun Nov 18 21:00:00 CST 2018, time=2018-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051245, encodeId=d8ce2051245a0, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Tue Feb 19 15:00:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1756009, encodeId=244c1e560096b, content=<a href='/topic/show?id=2e3269002f5' target=_blank style='color:#2F92EE;'>#生存时间#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69002, encryptionId=2e3269002f5, topicName=生存时间)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03a637065096, createdName=lilili1116, createdTime=Tue Oct 02 11:00:00 CST 2018, time=2018-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047021, encodeId=8fa3204e021c1, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Mon Dec 03 05:00:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1929515, encodeId=9dde19295155c, content=<a href='/topic/show?id=9e604625ab' target=_blank style='color:#2F92EE;'>#Chest#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4625, encryptionId=9e604625ab, topicName=Chest)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Tue Apr 23 03:00:00 CST 2019, time=2019-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469866, encodeId=990714698661d, content=<a href='/topic/show?id=c5de9405248' target=_blank style='color:#2F92EE;'>#过敏性肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94052, encryptionId=c5de9405248, topicName=过敏性肺炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58c67086533, createdName=vera_1205, createdTime=Mon Sep 24 00:00:00 CST 2018, time=2018-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535186, encodeId=fa98153518649, content=<a href='/topic/show?id=099f9020145' target=_blank style='color:#2F92EE;'>#表型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90201, encryptionId=099f9020145, topicName=表型)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6412593156, createdName=tastas, createdTime=Mon Sep 24 00:00:00 CST 2018, time=2018-09-24, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1808550, encodeId=aabd18085507d, content=<a href='/topic/show?id=02918204162' target=_blank style='color:#2F92EE;'>#肺功能轨迹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82041, encryptionId=02918204162, topicName=肺功能轨迹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a44345, createdName=yulin2006, createdTime=Sun Nov 18 21:00:00 CST 2018, time=2018-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051245, encodeId=d8ce2051245a0, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Tue Feb 19 15:00:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1756009, encodeId=244c1e560096b, content=<a href='/topic/show?id=2e3269002f5' target=_blank style='color:#2F92EE;'>#生存时间#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69002, encryptionId=2e3269002f5, topicName=生存时间)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03a637065096, createdName=lilili1116, createdTime=Tue Oct 02 11:00:00 CST 2018, time=2018-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047021, encodeId=8fa3204e021c1, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Mon Dec 03 05:00:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1929515, encodeId=9dde19295155c, content=<a href='/topic/show?id=9e604625ab' target=_blank style='color:#2F92EE;'>#Chest#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4625, encryptionId=9e604625ab, topicName=Chest)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Tue Apr 23 03:00:00 CST 2019, time=2019-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469866, encodeId=990714698661d, content=<a href='/topic/show?id=c5de9405248' target=_blank style='color:#2F92EE;'>#过敏性肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94052, encryptionId=c5de9405248, topicName=过敏性肺炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58c67086533, createdName=vera_1205, createdTime=Mon Sep 24 00:00:00 CST 2018, time=2018-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535186, encodeId=fa98153518649, content=<a href='/topic/show?id=099f9020145' target=_blank style='color:#2F92EE;'>#表型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90201, encryptionId=099f9020145, topicName=表型)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6412593156, createdName=tastas, createdTime=Mon Sep 24 00:00:00 CST 2018, time=2018-09-24, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1808550, encodeId=aabd18085507d, content=<a href='/topic/show?id=02918204162' target=_blank style='color:#2F92EE;'>#肺功能轨迹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82041, encryptionId=02918204162, topicName=肺功能轨迹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a44345, createdName=yulin2006, createdTime=Sun Nov 18 21:00:00 CST 2018, time=2018-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051245, encodeId=d8ce2051245a0, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Tue Feb 19 15:00:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1756009, encodeId=244c1e560096b, content=<a href='/topic/show?id=2e3269002f5' target=_blank style='color:#2F92EE;'>#生存时间#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69002, encryptionId=2e3269002f5, topicName=生存时间)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03a637065096, createdName=lilili1116, createdTime=Tue Oct 02 11:00:00 CST 2018, time=2018-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047021, encodeId=8fa3204e021c1, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Mon Dec 03 05:00:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1929515, encodeId=9dde19295155c, content=<a href='/topic/show?id=9e604625ab' target=_blank style='color:#2F92EE;'>#Chest#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4625, encryptionId=9e604625ab, topicName=Chest)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Tue Apr 23 03:00:00 CST 2019, time=2019-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469866, encodeId=990714698661d, content=<a href='/topic/show?id=c5de9405248' target=_blank style='color:#2F92EE;'>#过敏性肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94052, encryptionId=c5de9405248, topicName=过敏性肺炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58c67086533, createdName=vera_1205, createdTime=Mon Sep 24 00:00:00 CST 2018, time=2018-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535186, encodeId=fa98153518649, content=<a href='/topic/show?id=099f9020145' target=_blank style='color:#2F92EE;'>#表型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90201, encryptionId=099f9020145, topicName=表型)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6412593156, createdName=tastas, createdTime=Mon Sep 24 00:00:00 CST 2018, time=2018-09-24, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1808550, encodeId=aabd18085507d, content=<a href='/topic/show?id=02918204162' target=_blank style='color:#2F92EE;'>#肺功能轨迹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82041, encryptionId=02918204162, topicName=肺功能轨迹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a44345, createdName=yulin2006, createdTime=Sun Nov 18 21:00:00 CST 2018, time=2018-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051245, encodeId=d8ce2051245a0, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Tue Feb 19 15:00:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1756009, encodeId=244c1e560096b, content=<a href='/topic/show?id=2e3269002f5' target=_blank style='color:#2F92EE;'>#生存时间#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69002, encryptionId=2e3269002f5, topicName=生存时间)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03a637065096, createdName=lilili1116, createdTime=Tue Oct 02 11:00:00 CST 2018, time=2018-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047021, encodeId=8fa3204e021c1, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Mon Dec 03 05:00:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1929515, encodeId=9dde19295155c, content=<a href='/topic/show?id=9e604625ab' target=_blank style='color:#2F92EE;'>#Chest#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4625, encryptionId=9e604625ab, topicName=Chest)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Tue Apr 23 03:00:00 CST 2019, time=2019-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469866, encodeId=990714698661d, content=<a href='/topic/show?id=c5de9405248' target=_blank style='color:#2F92EE;'>#过敏性肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94052, encryptionId=c5de9405248, topicName=过敏性肺炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58c67086533, createdName=vera_1205, createdTime=Mon Sep 24 00:00:00 CST 2018, time=2018-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535186, encodeId=fa98153518649, content=<a href='/topic/show?id=099f9020145' target=_blank style='color:#2F92EE;'>#表型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90201, encryptionId=099f9020145, topicName=表型)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6412593156, createdName=tastas, createdTime=Mon Sep 24 00:00:00 CST 2018, time=2018-09-24, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1808550, encodeId=aabd18085507d, content=<a href='/topic/show?id=02918204162' target=_blank style='color:#2F92EE;'>#肺功能轨迹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82041, encryptionId=02918204162, topicName=肺功能轨迹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a44345, createdName=yulin2006, createdTime=Sun Nov 18 21:00:00 CST 2018, time=2018-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051245, encodeId=d8ce2051245a0, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Tue Feb 19 15:00:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1756009, encodeId=244c1e560096b, content=<a href='/topic/show?id=2e3269002f5' target=_blank style='color:#2F92EE;'>#生存时间#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69002, encryptionId=2e3269002f5, topicName=生存时间)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03a637065096, createdName=lilili1116, createdTime=Tue Oct 02 11:00:00 CST 2018, time=2018-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047021, encodeId=8fa3204e021c1, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Mon Dec 03 05:00:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1929515, encodeId=9dde19295155c, content=<a href='/topic/show?id=9e604625ab' target=_blank style='color:#2F92EE;'>#Chest#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4625, encryptionId=9e604625ab, topicName=Chest)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Tue Apr 23 03:00:00 CST 2019, time=2019-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469866, encodeId=990714698661d, content=<a href='/topic/show?id=c5de9405248' target=_blank style='color:#2F92EE;'>#过敏性肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94052, encryptionId=c5de9405248, topicName=过敏性肺炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58c67086533, createdName=vera_1205, createdTime=Mon Sep 24 00:00:00 CST 2018, time=2018-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535186, encodeId=fa98153518649, content=<a href='/topic/show?id=099f9020145' target=_blank style='color:#2F92EE;'>#表型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90201, encryptionId=099f9020145, topicName=表型)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6412593156, createdName=tastas, createdTime=Mon Sep 24 00:00:00 CST 2018, time=2018-09-24, status=1, ipAttribution=)]
    2019-04-23 Smile2680
  6. [GetPortalCommentsPageByObjectIdResponse(id=1808550, encodeId=aabd18085507d, content=<a href='/topic/show?id=02918204162' target=_blank style='color:#2F92EE;'>#肺功能轨迹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82041, encryptionId=02918204162, topicName=肺功能轨迹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a44345, createdName=yulin2006, createdTime=Sun Nov 18 21:00:00 CST 2018, time=2018-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051245, encodeId=d8ce2051245a0, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Tue Feb 19 15:00:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1756009, encodeId=244c1e560096b, content=<a href='/topic/show?id=2e3269002f5' target=_blank style='color:#2F92EE;'>#生存时间#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69002, encryptionId=2e3269002f5, topicName=生存时间)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03a637065096, createdName=lilili1116, createdTime=Tue Oct 02 11:00:00 CST 2018, time=2018-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047021, encodeId=8fa3204e021c1, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Mon Dec 03 05:00:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1929515, encodeId=9dde19295155c, content=<a href='/topic/show?id=9e604625ab' target=_blank style='color:#2F92EE;'>#Chest#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4625, encryptionId=9e604625ab, topicName=Chest)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Tue Apr 23 03:00:00 CST 2019, time=2019-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469866, encodeId=990714698661d, content=<a href='/topic/show?id=c5de9405248' target=_blank style='color:#2F92EE;'>#过敏性肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94052, encryptionId=c5de9405248, topicName=过敏性肺炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58c67086533, createdName=vera_1205, createdTime=Mon Sep 24 00:00:00 CST 2018, time=2018-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535186, encodeId=fa98153518649, content=<a href='/topic/show?id=099f9020145' target=_blank style='color:#2F92EE;'>#表型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90201, encryptionId=099f9020145, topicName=表型)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6412593156, createdName=tastas, createdTime=Mon Sep 24 00:00:00 CST 2018, time=2018-09-24, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1808550, encodeId=aabd18085507d, content=<a href='/topic/show?id=02918204162' target=_blank style='color:#2F92EE;'>#肺功能轨迹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82041, encryptionId=02918204162, topicName=肺功能轨迹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a44345, createdName=yulin2006, createdTime=Sun Nov 18 21:00:00 CST 2018, time=2018-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051245, encodeId=d8ce2051245a0, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Tue Feb 19 15:00:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1756009, encodeId=244c1e560096b, content=<a href='/topic/show?id=2e3269002f5' target=_blank style='color:#2F92EE;'>#生存时间#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69002, encryptionId=2e3269002f5, topicName=生存时间)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03a637065096, createdName=lilili1116, createdTime=Tue Oct 02 11:00:00 CST 2018, time=2018-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047021, encodeId=8fa3204e021c1, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Mon Dec 03 05:00:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1929515, encodeId=9dde19295155c, content=<a href='/topic/show?id=9e604625ab' target=_blank style='color:#2F92EE;'>#Chest#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4625, encryptionId=9e604625ab, topicName=Chest)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Tue Apr 23 03:00:00 CST 2019, time=2019-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469866, encodeId=990714698661d, content=<a href='/topic/show?id=c5de9405248' target=_blank style='color:#2F92EE;'>#过敏性肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94052, encryptionId=c5de9405248, topicName=过敏性肺炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58c67086533, createdName=vera_1205, createdTime=Mon Sep 24 00:00:00 CST 2018, time=2018-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535186, encodeId=fa98153518649, content=<a href='/topic/show?id=099f9020145' target=_blank style='color:#2F92EE;'>#表型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90201, encryptionId=099f9020145, topicName=表型)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6412593156, createdName=tastas, createdTime=Mon Sep 24 00:00:00 CST 2018, time=2018-09-24, status=1, ipAttribution=)]
    2018-09-24 tastas

相关资讯

Respir Med Case Rep:过敏性肺炎患者的肺气肿变化

肺气肿最常见的原因是吸烟,但是在过敏性肺炎(HP)中也会出现肺气肿。本研究旨在进一步探究二者之间的关联。 1997年1月至2014年2月,研究人员在明尼苏达州罗切斯特的梅奥诊所进行了回顾性计算机辅助检索以确定HP患者。分析人口统计学临床和影像学特征。排除吸烟史为10包年或更长的患者。 最终研究确定了12名患有HP的患者(9名男性),计算机断层扫描确诊了肺气肿。10名患者为从不吸烟者,另外2名是戒烟